The influence of renally inappropriate medication on the frailty of elderly patients with diabetes
- VernacularTitle:肾脏不适当用药对老年糖尿病患者衰弱的影响
- Author:
Wanying YANG
1
;
Xiangming ZHOU
2
;
Yuanyuan MIAO
2
;
Yunhui ZHAO
1
;
Lu WANG
1
;
Tingyu KE
2
;
Lili BAN
1
Author Information
1. Dept. of Pharmacy，the Second Affiliated Hospital of Kunming Medical University，Kunming 650106，China
2. Dept. of Endocrinology，the Second Affiliated Hospital of Kunming Medical University，Kunming 650106，China
- Publication Type:Journal Article
- Keywords:
renally inappropriate medication;
frailty;
elderly;
diabetes;
propensity score matching
- From:
China Pharmacy
2024;35(2):214-218
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the effects of renally inappropriate medication （RIM） on the frailty of elderly patients with diabetes. METHODS The data of elderly patients with diabetes mellitus admitted to a third-grade class A hospital in Yunnan province from January to December 2022 were collected， and Beers criteria （2019 edition） and Chinese version of FRAIL scale were used to evaluate RIM and the frailty of the patients； the patients were divided into the trial group （with RIM） and the control group （without RIM） according to whether there was RIM. The propensity score matching was used to balance confounding factors between two groups， and the influence of RIM on the frailty of elderly diabetic patients was analyzed by the Logistic regression model. RESULTS Among the 367 patients， 80 patients （21.80%） had RIM， the drugs involved RIM were spironolactone （82.56%）， rivaroxaban （13.95%） and gabapentin （3.49%）. After reaching the balance between groups using the propensity score matching method， the incidence of frailty was 77.94% in trial group and 27.94% in control group （P＜0.001）； the difference was not statistically significant in other confounding factors between the two groups （P＞0.05）. Results of Logistic regression analysis showed that the risk of frailty in the experimental group was 3.118 times that of the control group （odds ratio was 3.118，95% confidence interval was 1.758-5.530， P＜0.001）. CONCLUSIONS RIM is a risk factor for the frailty of elderly patients with diabetes， which can be considered as an indicator for early identification and screening of the frailty of elderly diabetes patients.
